347 related articles for article (PubMed ID: 27830940)
1. Challenges in Implementing a Biorisk Management Program at Universitas Indonesia: A Checklist Tool for Biorisk Management.
Naroeni A; Bachtiar EW; Ibrahim F; Bela B; Kusminanti Y; Pujiriani I; Lestari F
Health Secur; 2016; 14(6):375-381. PubMed ID: 27830940
[TBL] [Abstract][Full Text] [Related]
2. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
Zaki AN
Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S70-4. PubMed ID: 20801002
[TBL] [Abstract][Full Text] [Related]
3. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.
Appelt S; Jacob D; Rohleder AM; Bråve A; Szekely Björndal Å; Di Caro A; Grunow R;
Euro Surveill; 2020 Sep; 25(36):. PubMed ID: 32914748
[TBL] [Abstract][Full Text] [Related]
4. International Society for Analytical Cytology biosafety standard for sorting of unfixed cells.
Schmid I; Lambert C; Ambrozak D; Marti GE; Moss DM; Perfetto SP;
Cytometry A; 2007 Jun; 71(6):414-37. PubMed ID: 17385740
[TBL] [Abstract][Full Text] [Related]
5. Harmonization of European laboratory response networks by implementing CWA 15793: use of a gap analysis and an "insider" exercise as tools.
Sundqvist B; Bengtsson UA; Wisselink HJ; Peeters BP; van Rotterdam B; Kampert E; Bereczky S; Johan Olsson NG; Szekely Björndal A; Zini S; Allix S; Knutsson R
Biosecur Bioterror; 2013 Sep; 11 Suppl 1():S36-44. PubMed ID: 23971820
[TBL] [Abstract][Full Text] [Related]
6. [Biorisk Management for Clinical Diagnostic Laboratories].
Shigematsu M
Rinsho Byori; 2016 Nov; 64(11):1279-1289. PubMed ID: 30695310
[TBL] [Abstract][Full Text] [Related]
7. Strengthening Biorisk Management Capacities in Burkina Faso: Contribution of the Global Health Security Agenda.
Dama E; Orelle A; Nikiema A; Mandingar PD; Naby A; Bationo GB; Kéita MS; Pierson A; Sawadogo C; Koné RG
Health Secur; 2022; 20(6):479-487. PubMed ID: 36399610
[TBL] [Abstract][Full Text] [Related]
8. A Cross-Sectional Survey to Assess Biorisk Management System in Research and Diagnostic Laboratories in Khyber Pakhtunkhwa, Pakistan.
Muhammad J; Sarwar S; Khan T; Qasmi SA; Ikram A; Ahmad G; Zahid M; Durrani RH; Ahmed F
Front Public Health; 2021; 9():766162. PubMed ID: 34976925
[TBL] [Abstract][Full Text] [Related]
9. Lessons to be Learned from Recent Biosafety Incidents in the United States.
Weiss S; Yitzhaki S; Shapira SC
Isr Med Assoc J; 2015 May; 17(5):269-73. PubMed ID: 26137650
[TBL] [Abstract][Full Text] [Related]
10. Biosafety Recommendations for Work with Influenza Viruses Containing a Hemagglutinin from the A/goose/Guangdong/1/96 Lineage.
; Gangadharan D; Smith J; Weyant R
MMWR Recomm Rep; 2013 Jun; 62(RR-06):1-7. PubMed ID: 23803973
[TBL] [Abstract][Full Text] [Related]
11. Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility.
Joseph T; Phyu S; Se-Thoe SY; Chu JJH
Methods Mol Biol; 2022; 2452():441-464. PubMed ID: 35554920
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, Biosafety Blue Ribbon Panel.
Miller JM; Astles R; Baszler T; Chapin K; Carey R; Garcia L; Gray L; Larone D; Pentella M; Pollock A; Shapiro DS; Weirich E; Wiedbrauk D; ;
MMWR Suppl; 2012 Jan; 61(1):1-102. PubMed ID: 22217667
[TBL] [Abstract][Full Text] [Related]
13. Safety management and risk assessment in chemical laboratories.
Marendaz JL; Friedrich K; Meyer T
Chimia (Aarau); 2011; 65(9):734-7. PubMed ID: 22026190
[TBL] [Abstract][Full Text] [Related]
14. [Biohazards in research laboratories].
Porru S; Chiappin M; Sfriso N
G Ital Med Lav Ergon; 2019 Dec; 41(4):359-364. PubMed ID: 32126610
[TBL] [Abstract][Full Text] [Related]
15. The Main Biological Hazards in Animal Biosafety Level 2 Facilities and Strategies for Control.
Li XY; Xue KN; Jiang JS; Lu XC
Biomed Environ Sci; 2016 Apr; 29(4):300-4. PubMed ID: 27241742
[TBL] [Abstract][Full Text] [Related]
16. WHO Laboratory Biosafety Manual: A New Approach to Security.
Ficociello B; Giordano D; Incoronato F; Farinella A; Pietrangeli B
Ann Work Expo Health; 2023 Apr; 67(4):425-429. PubMed ID: 36495279
[TBL] [Abstract][Full Text] [Related]
17. Guidelines for Biosafety Training Programs for Workers Assigned to BSL-3 Research Laboratories.
Homer LC; Alderman TS; Blair HA; Brocard AS; Broussard EE; Ellis RP; Frerotte J; Low EW; McCarthy TR; McCormick JM; Newton JM; Rogers FC; Schlimgen R; Stabenow JM; Stedman D; Warfield C; Ntiforo CA; Whetstone CT; Zimmerman D; Barkley E
Biosecur Bioterror; 2013 Mar; 11(1):10-9. PubMed ID: 23477631
[TBL] [Abstract][Full Text] [Related]
18. [Biosafety provision on handling pathogenic biological agents on the concept of biorisk assessment and management].
Dobrokhotskiĭ ON; Kolombet LV
Gig Sanit; 2010; (5):79-81. PubMed ID: 21344700
[TBL] [Abstract][Full Text] [Related]
19. Biosafety considerations in laboratory design.
Mortland KK; Mortland DB
Clin Leadersh Manag Rev; 2003; 17(3):175-7. PubMed ID: 12813961
[No Abstract] [Full Text] [Related]
20. [Protection of medical diagnostic laboratory workers against biohazards].
Kozajda A; Szadkowska-Stańczyk I
Med Pr; 2011; 62(3):291-5. PubMed ID: 21870419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
